Evidence map›Paper›PMID 18283504›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2008

Candida infective endocarditis.

J W Baddley, D K Benjamin, M Patel, J Miró, E Athan, B Barsic, E Bouza, L Clara, T Elliott, Z Kanafani and 12 more

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 3 pooled it
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 3 syntheses or guidelines pooled it, 209 citations in OpenAlex.

  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Guideline
  2. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009
    Guideline
  3. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  4. Trial
  5. Review
  6. Review
  7. Antifungal Therapy in Candida Infective Endocarditis: A Comparison of Echinocandins and Other Treatment Regimens in a Nationwide Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  8. Fatal Complications inJournal of fungi (Basel, Switzerland) · 2025
    Article
  9. A Review of Current Insights in Fungal Endocarditis.Journal of clinical medicine · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. InvasiveOpen forum infectious diseases · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Patients with Artificial Heart Valves.Deutsches Arzteblatt international · 2023
    Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 18 institutions in 9 countries.

J W BaddleyDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-0006, USA. jbaddley@uab.edu
D K Benjamin
M Patel
J Miró
E Athan
B Barsic
E Bouza
L Clara
T Elliott
Z Kanafani
J Klein
S Lerakis
D Levine
D Spelman
E Rubinstein
P Tornos
A J Morris
P Pappas
V G Fowler
V H Chu
C Cabell
International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS)
Duke University · USAmerican University of Beirut Medical Center · LBAuckland City Hospital · NZBarwon Health · AUBirmingham VA Medical Center · USClinical Research Institute · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESEmory University Hospital · USHospital General Universitario Gregorio Marañón · ESHospital Italiano de Buenos Aires · ARQueen Elizabeth Hospital Birmingham · GBSt Thomas' Hospital · GBThe Alfred Hospital · AUUniversity Hospital for Infectious Diseases "Dr Fran Mihaljevic" · HRUniversity of Alabama at Birmingham · USUniversity of Manitoba · CAVall d'Hebron Hospital Universitari · ESWayne State University · US

Funding

Early Diagnosis of Neonatal CandidiasisK23HD044799 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K. · 2005 to 2008
$610k
NICHD NIH HHS K23HD-0044799NICHD NIH HHS K23 HD044799
6 · The paper itself

Abstract

Candida infective endocarditis (IE) is uncommon but often fatal. Most epidemiologic data are derived from small case series or case reports. This study was conducted to explore the epidemiology, treatment patterns, and outcomes of patients with Candida IE. We compared 33 Candida IE cases to 2,716 patients with non-fungal IE in the International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS). Patients were enrolled and the data collected from June 2000 until August 2005. We noted that patients with Candida IE were more likely to have prosthetic valves (p < 0.001), short-term indwelling catheters (p < 0.0001), and have healthcare-associated infections (p < 0.001). The reasons for surgery differed between the two groups: myocardial abscess (46.7% vs. 22.2%, p = 0.026) and persistent positive blood cultures (33.3% vs. 9.9%, p = 0.003) were more common among those with Candida IE. Mortality at discharge was higher in patients with Candida IE (30.3%) when compared to non-fungal cases (17%, p = 0.046). Among Candida patients, mortality was similar in patients who received combination surgical and antifungal therapy versus antifungal therapy alone (33.3% vs. 27.8%, p = 0.26). New antifungal drugs, particularly echinocandins, were used frequently. These multi-center data suggest distinct epidemiologic features of Candida IE when compared to non-fungal cases. Indications for surgical intervention are different and mortality is increased. Newer antifungal treatment options are increasingly used. Large, multi-center studies are needed to help better define Candida IE.

Indexed as

AdultAgedAntifungal AgentsCandidaCandidiasisCatheters, IndwellingCross InfectionEndocarditisFemaleHumansMaleMiddle AgedProstheses and ImplantsRisk FactorsAntifungal Agents

Identifiers

PMID18283504
PMCPMC2757733
OpenAlexW2038616456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.